hepatitis News

The Center for the Biology of Chronic Disease Points Out an All Natural Remedy without Side Effects

The CBCD is concerned that a new, potential Hepatitis C vaccine could cause Microcompetition due to its “gene based” nature.

Contaminated samples of sun-dried tomatoes could be to blame for the infection that hospitalized four people and caused another three to fall ill in late 2011.

Local doctors in Iowa City, IA say they are not surprised by recent information released by the CDC regarding deaths related to Hepatitis C.

The CBCD has learned that Auckland, NZ is facing a hepatitis A outbreak with 19 cases confirmed, including some schoolchildren.

The CBCD has learned that Stanford researchers used a new computer model of HCV to show that two new drugs intended to target the virus are cost-effective.

A new report from the AFP news agency says “More Americans died in 2007 of hepatitis C infection, which causes incurable liver disease, than from the virus that causes AIDS."

“Deaths from liver-destroying hepatitis C are on the rise.” The virus, which affects 170 million people worldwide, can gradually scar the liver and lead to cirrhosis or liver cancer.

Scientists from MIT, Rockefeller University and the Medical College of Wisconsin have found a technique to generate liver-like cells made from stem cells.

A new national helpline, 877-HELP-4-HEP, run by and for people affected by hepatitis C will formally launch February 1, 2012.

Merck Pharmaceuticals announced that it was planning on “making whatever deals are necessary” to make sure the company maintains its lead in developing and manufacturing oral medications to treat the Hepatitis C virus.

The Center for the Biology of Chronic Disease (CBCD) has recently learned that Bristol-Myers Squibb Co. will lose patent protection for three of its top four drugs within the next three years.

A paper published ahead of print in the Journal of Infectious Diseases says that Chronic Hepatitis B virus (HBV) infection almost doubles the risk of AIDS or death in people diagnosed with HIV infection.

NIH Sponsored Investigator Dr. David Kingston from Virginia Tech Gains Access to the Formerly Private Merck Natural Products Collection

A committee convened by the National Academy of Sciences has released a report establishing the first set of criteria for research on chimpanzees.

Bristol-Myers Squibb is now collaborating on the development of a new Hepatitis C therapy with Tibotec Pharmaceuticals.

The Center for the Biology of Chronic Disease (CBCD) applauds Danish insulin giant, Novo Nordisk’s decision to stop using live animals in biological product control tests.

Over two million people in India die due to chronic liver disease. Of them, 15% are infected with the Hepatitis C virus (HCV) while 45 % die due to the Hepatitis B virus (HBV).

German researchers believe a substance found in green tea may offer an antiviral strategy to prevent Hepatitis C “reinfection."

The Center for the Biology of Chronic Disease (CBCD) has learned that there is a shortage of Hepatitis B (HBV) vaccine in Nagpur city, India.

Apparently the Hepatitis C drug Incivek manufactured by pharmaceutical company, Vertex and Victrelis, a competing HCV drug which is manufactured by Merk & Co., Inc. are no longer just fighting each other for marketplace dominance.

Vertex Pharmaceuticals’ new drug, “Incivek” has beaten Merck’s “Victrelis’s” sales by a gigantic margin.

New Trends in Preventive and Therapeutic Vaccines: R&D Activities and Commercial Prospects

Bristol-Myers Squibb Co.'s new drug called BMS-790052 in combination with peginterferon and ribavirin cured up to 83% of patients infected with Hepatitis C.

polyDNA, the makers of Gene-Eden-Blue congratulates Pharmasset, Inc. on the success of a new study described as a “home run” in the fight against viral Hepatitis C.

Gene-Eden Blue is First Antiviral, All Natural Remedy Against Latent HCV with Extremely Reasonable Price.

polyDNA, Makers of Gene-Eden Blue, Joins FAIR in Urging HIV Advocates and Researchers to Consider Focusing on Battling Two of the Greatest Killers of HIV/AIDS Patients: Viral Hepatitis and Diabetes.

According to an article authored by Ravi Jhaveri, MD and published through Medscape, symptoms for Hepatitis B (HBV) are seen in about 30% of children who are infected with the virus.

Only a third of those infected with Hepatitis B (HBV) actually know it. It is estimated that as many as 2,000,000 people are infected in the U.S. alone.

In the world, 500 million people are living with Hepatitis B or C. And only a small percentage of them are aware of this fact.

A comprehensive portal for people living with hepatitis and their care providers

Bpogen is the latest product developed from bio-technically developed spirulina. An adequate usage of FEBICO Bpogen capsules, is the solution to building up strength, reducing fatigue, and good circulation.

New Healthcare market report from Datamonitor: "R&D Trends: Hepatitis C"

ORGENTEC has developed a new lab test for diagnosing autoimmune liver diseases. The immunoblot is suitable for initial and differential diagnosis in cases of ambiguous symptoms or for differentiation of a positive result from screening tests.

New Pharmaceuticals market report from Datamonitor: "Epidemiology: Hepatitis B in China"

Fast Market Research recommends "Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2017" from GlobalData, now available

Liquorice in recent studies has been shown to have numerous antiviral effects. As a medicinal compound, liquorice shows promise in the development of new antiviral medications and supplements.

Dr. Norman Cohen reviews Gene-Eden, an all-natural antiviral health supplement.

Bharatbook.com announces inclusion of latest report on "Brief : Hepatitis C/AASLD 2010

Immunolizer® is a natural formula scientifically designed to optimize the immune system's performance. Immunolizer® activates the body's defense mechanisms and helps the Immune System to distinguish adequately between self and non-self.

Dr. Zhijian "James" Chen, an HHMI investigator and leading ubiquitinologist, will speak at the upcoming 2011 Ubiquitin Drug Discovery & Diagnostics conference.

New Pharmaceuticals market report from Business Insights: "The Hepatitis Market Outlook to 2015: Competitive landscape, market size, pipeline analysis and growth opportunities"

New Pharmaceuticals market report from GlobalData: "Hepatitis B Vaccines - Pipeline Assessment and Market Forecasts to 2017"

New Healthcare market report from Business Monitor International: "Bangladesh Pharmaceuticals & Healthcare Report Q4 2010"

Because DNA vaccines generate cell-mediated immunity, the hope is that they will be effective against difficult viruses, even in cases where standard vaccines have failed to work.

A Reliable and Cost-Effective Means to Differentiate Between Latent and Infectious m. Tuberculosis

Gene-Eden, an all-natural anti-viral dietary supplement, has been shown to help the immune system fight Hepatitis C. The following is a review of a satisfied customer who was able to reduce her viral load of Hepatitis C with regular use of Gene Eden.

Fatty liver disease, as the term implies, is the accumulation of fats in the liver cells. This occurrence is hampering the liver’s function in cleaning and filtering the blood to increase circulation.

The fatty liver solution is an amazing ebook developed by Duncan Capicchiano which is intended for all individuals who are suffering from fatty liver.

Fatty liver or also referred to as steatosis is the accumulation of fat in the liver. Liver is one of the major organs in the human body and responsible for the metabolism of fat.